Right now, patients with obesity and cirrhosis have few treatments for their progressive liver disease, but a new study ...
Liver cancer is the sixth most common cancer in the world and the 16th most common in the UK - but it is often detected too ...
Akero reported Monday strong results showing its drug efruxifermin reversed liver scarring in patients with cirrhosis caused ...
A dietary supplement used to build muscle – or prevent muscle loss as a result of ageing or illness – is to be trialled as a potential treatment for chronic liver disease.
Rutgers Health researchers find that allergy medicine could help patients with a rare genetic disease avoid liver transplants ...
Salk scientists have found that eliminating the bile acid-producing protein BAAT and supplementing with the bile acid UDCA ...
A Cleveland Clinic study reveals that bariatric surgery significantly reduces the risk of serious liver complications in ...
Adding a monoclonal antibody cocktail to the standard treatment for inoperable liver cancer nearly doubled the amount of time ...
Akero's SYMMETRY Phase 2b study showed 50mg EFX achieved 24% cirrhosis reversal in MASH patients, with improvements in liver ...
Multidisciplinary care is needed to ensure positive maternal and fetal health outcomes, especially in complex or high-risk ...
January marks Love Your Liver month, prompting a doctor to raise awareness about liver cancer, a condition often detected at ...